These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 23382105

  • 1. Population pharmacokinetics and dose optimization of mycophenolic acid in HCT recipients receiving oral mycophenolate mofetil.
    Li H, Mager DE, Sandmaier BM, Maloney DG, Bemer MJ, McCune JS.
    J Clin Pharmacol; 2013 Apr; 53(4):393-402. PubMed ID: 23382105
    [Abstract] [Full Text] [Related]

  • 2. Differences in clearance of mycophenolic acid among renal transplant recipients, hematopoietic stem cell transplant recipients, and patients with autoimmune disease.
    de Winter BC, Mathot RA, Sombogaard F, Neumann I, van Hest RM, Doorduijn JK, van Gelder T.
    Ther Drug Monit; 2010 Oct; 32(5):606-14. PubMed ID: 20720518
    [Abstract] [Full Text] [Related]

  • 3. Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.
    Musuamba FT, Rousseau A, Bosmans JL, Senessael JJ, Cumps J, Marquet P, Wallemacq P, Verbeeck RK.
    Clin Pharmacokinet; 2009 Oct; 48(11):745-58. PubMed ID: 19817503
    [Abstract] [Full Text] [Related]

  • 4. Population pharmacokinetics of mycophenolic acid in renal transplant recipients.
    van Hest RM, van Gelder T, Vulto AG, Mathot RA.
    Clin Pharmacokinet; 2005 Oct; 44(10):1083-96. PubMed ID: 16176120
    [Abstract] [Full Text] [Related]

  • 5. Population pharmacokinetics of mycophenolic acid and dose optimization with limited sampling strategy in liver transplant children.
    Barau C, Furlan V, Debray D, Taburet AM, Barrail-Tran A.
    Br J Clin Pharmacol; 2012 Sep; 74(3):515-24. PubMed ID: 22329639
    [Abstract] [Full Text] [Related]

  • 6. A limited sampling schedule to estimate mycophenolic Acid area under the concentration-time curve in hematopoietic cell transplantation recipients.
    Li H, Mager DE, Bemer MJ, Salinger DH, Vicini P, Sandmaier BM, Nash R, McCune JS.
    J Clin Pharmacol; 2012 Nov; 52(11):1654-64. PubMed ID: 22174435
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients.
    de Winter BC, van Gelder T, Sombogaard F, Shaw LM, van Hest RM, Mathot RA.
    J Pharmacokinet Pharmacodyn; 2009 Dec; 36(6):541-64. PubMed ID: 19904584
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic modelling and development of Bayesian estimators for therapeutic drug monitoring of mycophenolate mofetil in reduced-intensity haematopoietic stem cell transplantation.
    Saint-Marcoux F, Royer B, Debord J, Larosa F, Legrand F, Deconinck E, Kantelip JP, Marquet P.
    Clin Pharmacokinet; 2009 Dec; 48(10):667-75. PubMed ID: 19743888
    [Abstract] [Full Text] [Related]

  • 9. Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.
    Tett SE, Saint-Marcoux F, Staatz CE, Brunet M, Vinks AA, Miura M, Marquet P, Kuypers DR, van Gelder T, Cattaneo D.
    Transplant Rev (Orlando); 2011 Apr; 25(2):47-57. PubMed ID: 21190834
    [Abstract] [Full Text] [Related]

  • 10. Population pharmacokinetics of mycophenolic acid : a comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients.
    de Winter BC, van Gelder T, Glander P, Cattaneo D, Tedesco-Silva H, Neumann I, Hilbrands L, van Hest RM, Pescovitz MD, Budde K, Mathot RA.
    Clin Pharmacokinet; 2008 Apr; 47(12):827-38. PubMed ID: 19026038
    [Abstract] [Full Text] [Related]

  • 11. A limited sampling model for estimation of total and unbound mycophenolic acid (MPA) area under the curve (AUC) in hematopoietic cell transplantation (HCT).
    Ng J, Rogosheske J, Barker J, Weisdorf D, Jacobson PA.
    Ther Drug Monit; 2006 Jun; 28(3):394-401. PubMed ID: 16778725
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine.
    Lobritto SJ, Rosenthal P, Bouw R, Leung M, Snell P, Mamelok RD.
    Liver Transpl; 2007 Nov; 13(11):1570-5. PubMed ID: 17969194
    [Abstract] [Full Text] [Related]

  • 13. Bayesian estimation of mycophenolate mofetil in lung transplantation, using a population pharmacokinetic model developed in kidney and lung transplant recipients.
    de Winter BC, Monchaud C, Prémaud A, Pison C, Kessler R, Reynaud-Gaubert M, Dromer C, Stern M, Guillemain R, Knoop C, Estenne M, Marquet P, Rousseau A.
    Clin Pharmacokinet; 2012 Jan 01; 51(1):29-39. PubMed ID: 22054177
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mycophenolic acid levels in pediatric heart transplant recipients receiving mycophenolate mofetil.
    Dipchand AI, Pietra B, McCrindle BW, Rosebrook-Bicknell HL, Boucek MM.
    J Heart Lung Transplant; 2001 Oct 01; 20(10):1035-43. PubMed ID: 11595558
    [Abstract] [Full Text] [Related]

  • 16. An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients.
    Bhatia M, Militano O, Jin Z, Figurski M, Shaw L, Moore V, Morris E, Tallamy B, van deVen C, Ayello J, Baxter-Lowe L, Satwani P, George D, Bradley MB, Garvin J, Cairo MS.
    Biol Blood Marrow Transplant; 2010 Mar 01; 16(3):333-43. PubMed ID: 19835971
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun 01; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetic study of mycophenolate mofetil in patients with systemic lupus erythematosus and design of Bayesian estimator using limited sampling strategies.
    Zahr N, Amoura Z, Debord J, Hulot JS, Saint-Marcoux F, Marquet P, Piette JC, Lechat P.
    Clin Pharmacokinet; 2008 Jun 01; 47(4):277-84. PubMed ID: 18336056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.